Simplex Trading
OLMA icon

Simplex Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Simplex Trading’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Sell
4,400
-31,300
-88% -$419K ﹤0.01% 6205
2026
Q1 		$532K Buy
35,700
+6,400
+22% +$142K ﹤0.01% 3181
2025
Q4 		$733K Sell
29,300
-42,900
-59% -$763K ﹤0.01% 2928
2025
Q3 		$706K Buy
72,200
+24,600
+52% +$148K ﹤0.01% 3416
2025
Q2 		$202K Buy
47,600
+46,600
+4,660% +$208K ﹤0.01% 4494
2025
Q1 		$3K Sell
1,000
-47,000
-98% -$236K ﹤0.01% 7851
2024
Q4 		$279K Buy
48,000
+40,700
+558% +$407K ﹤0.01% 4147
2024
Q3 		$87K Sell
7,300
-5,000
-41% -$63.9K ﹤0.01% 5375
2024
Q2 		$133K Buy
12,300
+9,400
+324% +$102K ﹤0.01% 5065
2024
Q1 		$32K Sell
2,900
-8,100
-74% -$105K ﹤0.01% 6703
2023
Q4 		$154K Buy
11,000
+5,500
+100% +$73.9K ﹤0.01% 4945
2023
Q3 		$67K Buy
5,500
+5,100
+1,275% +$52K ﹤0.01% 5526
2023
Q2 		$3K Buy
+400
New +$2.42K ﹤0.01% 8255
2022
Q1 		– Sell
-1,700
Closed -$15K – 11115
2021
Q4 		$15K Buy
+1,700
New +$35.2K ﹤0.01% 8693

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Simplex Trading's OLMA Position: Q2 2026 in Review

Simplex Trading sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 11,127 shares — an estimated $149K sold.

Simplex Trading first reported a position in OLMA in Q4 2021 and held it in 12 quarters. The position peaked at $261K in Q4 2023. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Simplex Trading reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 11,127 Olema Pharmaceuticals shares in Q2 2026, an estimated $149K.
  • Simplex Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 12 quarters.
  • Simplex Trading's Olema Pharmaceuticals position peaked at $261K in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.